Africa Resilience Initiative

highcountryhealth.com - by C. Louis “pj” Perrinjaquet, MD - June 12, 2014

As may become clear if you continue reading… I’m a doctor not a writer.  But, just as I was compelled to volunteer the past 6 weeks in the Nuba Mts. of Sudan, I am compelled to write and tell the story of what is happening there. 

Since May 2011 when the government on Sudan in Khartoum launched a campaign “to exterminate the Nuba people like bugs”, the civilian population has been subjected to daily aerial bombardment and has been denied access to humanitarian aid.  Unable to plant crops people are starving to death or surviving on bugs and grass, risking death to venture outside their caves in search of food and water.

The one hospital in the entire Nuba Mts, Mother of Mercy in Gidel, staffed by one fulltime physician, Dr. Tom Catena,  have been spared bombardment… until last month.

The following is taken directly from my journal written when the events were fresh.

When a team from Tulane University sent a batch of protective clothing and equipment to help workers fighting an outbreak of Ebola virus in Sierra Leone last month, they were fairly confident the 300 or so packs would be enough for a good start.

They couldn’t have predicted what they would be up against.

Certains individus mal intentionnés n’ont aucun mal à transformer un morceau de craie, un peu de farine ou d’amidon en un comprimé ou une pilule. Difficile de dire à l’œil nu s’il s’agit d’un « faux ». L’étiquetage et l’emballage sont souvent imités à la perfection. Le commerce mondial de médicaments de contrefaçon, qui pèse un milliard de dollars, se porte bien en Afrique. Les médicaments contrefaits et de mauvaise qualité inondent les marchés. Se rendre à la pharmacie, c’est un peu jouer à la roulette russe. Choisir la mauvaise boîte peut vous coûter la vie.

En Afrique, selon l’Organisation mondiale de la santé (OMS), près de 100 000 décès par...

In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. Virologic investigation identified Zaire ebolavirus (EBOV) as the causative agent. Full-length genome sequencing and phylogenetic analysis showed that EBOV from Guinea forms a separate clade in relationship to the known EBOV strains from the Democratic Republic of Congo and Gabon. Epidemiologic investigation linked the laboratory-confirmed cases with the presumed first fatality of the outbreak in December 2013. This study demonstrates the emergence of a new EBOV strain in Guinea.

CLICK HERE TO READ MORE